The FDA’s View on CTO PCI: Why Everyday Devices Need CTO Specific Indications - Tara A Ryan, MD, MBA

↳ This is a section part of Moment: CRT 2015 Coronary - Session 1: Like It or Not You Need to Know the Data

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

The FDA’s View on CTO PCI: Why Everyday Devices Need CTO Specific Indications presented by Tara A Ryan, MD, MBA at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Session 1: Like It or Not You Need to Know the Data

Track: Coronary

Learning Objectives

  • Update in advances in CTO

Other Components in this Moment

Overview
Histopathologic Insights into Chronically Occluded Coronary Arteries – The Post-CABG vs Unbypassed CTO - Renu Virmani, MD
Native Coronary Patency after CABG Surgery: Clinical Implications - B. Strauss, MD, PhD
The Rationale for CTO PCI: The Latest on Symptom Relief and Survival From Registries and Meta Analyses - Carlo Di Mario, MD
Success and Safety of Contemporary CTO-PCI: The Latest From Recent Registries and Meta Analyses - D. Karmpaliotis , MD, PhD
Ongoing Randomized Trials: Where They Stand and What They Stand To Prove or Disprove - Gerald S. Werner, MD, PhD
The FDA’s View on CTO PCI: Why Everyday Devices Need CTO Specific Indications - Tara A Ryan, MD, MBA
Loading Simple Education